After finding support at $30, Moderna (MRNA) added nearly $5.00 to close at $35.21. The firm participated in TD Cowen’s annual healthcare conference.
Moderna said it wants to expand its vaccine to have the broadest label. That would increase its competitiveness compared to Pfizer (PFE) and GSK (GSK). Healthcare providers would prefer the convenience factor of a pre-filled syringe for flu and Covid vaccination.
Markets did not react negatively to the Patent Trial and Appeals Board of the U.S. Patent and Trademark Office throwing out parts of two patents that Moderna held.
Celanese (CE) added 12.69% to close at $54.33 on Wednesday. Bargain hunters are betting that the downtrend is nearing an end. In addition, the specialty materials company would benefit if Trump eased tariff threat rates. Chemicals and mining firms are among the sectors that face pressure with such trade barriers in place.
Huntington Ingalls Industries (HII) unexpectedly gained 12.36% yesterday. The stock, which peaked at $295.74 in the last year, closed at $193.59. President Trump’s announcement on plans to invest in the shipbuilding industry set off a rally. Defense contractors also rallied. This included Lockheed Martin (LMT), L3Harris (LHX), RTX (RTX), and General Dynamics (GD).
Related Stories
